Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher J. Gostout currently holds 90,267 shares of Apollo Endosurgery, Inc. (APEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Gostout has been a net neutral trader of APEN stock. They have purchased $0 and sold $0 worth of shares.
Christopher J. Gostout's most recent insider trade was on Apr 4, 2023, when they sold 90,267 shares at $0.00 per share.
Christopher J. Gostout serves as Executive at Apollo Endosurgery, Inc. (APEN). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Christopher J. Gostout holds the position of Executive at Apollo Endosurgery, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Christopher J. Gostout has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher J. Gostout was on Apr 4, 2023, when they sold $0 worth of APEN shares. This transaction involved 90,267 shares at N/A per share.
Christopher J. Gostout currently owns 90,267 shares of Apollo Endosurgery, Inc. (APEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher J. Gostout's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher J. Gostout has 6 Form 4 filings on record as an insider at Apollo Endosurgery, Inc..
Set alerts for Christopher J. Gostout and 40,000+ other insiders.